Fang Wei

Title: Innovations of Fang Wei in Exosomal Biomarker Detection

Introduction

Fang Wei is an accomplished inventor based in Santa Monica, CA. He has made significant contributions to the field of biomarker detection, particularly in the context of lung cancer. With a total of 4 patents to his name, Fang Wei is recognized for his innovative approaches to medical diagnostics.

Latest Patents

One of Fang Wei's latest patents is focused on "Non-Invasive Gene Mutation Detection in Lung Cancer Patients." This patent introduces a method for exosomal biomarker detection through electric field-induced release and measurement. The research highlights the importance of molecules harbored in exosomes, which play crucial roles in biological science. The Electric Field Induced Release and Measurement (EFIRM) technique allows for the rapid and simultaneous tracking and quantification of these biomolecules. By using an electrical field, the method disrupts exosomes to release their contents, enabling the measurement of exosomal RNA and proteins within minutes. This innovative approach provides a potential on-site method for detecting exosome-harbored biomolecules.

Career Highlights

Fang Wei is affiliated with the University of California, where he continues to advance research in the field of exosomal biomarkers. His work has garnered attention for its potential applications in non-invasive cancer diagnostics.

Collaborations

Fang Wei collaborates with notable colleagues, including Wei Liao and Na Li, who contribute to his research endeavors.

Conclusion

Fang Wei's innovative work in exosomal biomarker detection represents a significant advancement in medical diagnostics. His contributions have the potential to improve non-invasive testing methods for lung cancer patients, showcasing the importance of innovation in healthcare.